DNA damage induced by topoisomerase inhibitors activates SAMHD1 and blocks HIV-1 infection of macrophages
journal contributionposted on 07.09.2020, 11:12 by Petra Mlcochova, Sarah J Caswell, Ian A Taylor, Greg J Towers, Ravindra K Gupta
We report that DNA damage induced by topoisomerase inhibitors, including etoposide (ETO), results in a potent block to HIV-1 infection in human monocyte-derived macrophages (MDM). SAMHD1 suppresses viral reverse transcription (RT) through depletion of cellular dNTPs but is naturally switched off by phosphorylation in a subpopulation of MDM found in a G1-like state. We report that SAMHD1 was activated by dephosphorylation following ETO treatment, along with loss of expression of MCM2 and CDK1, and reduction in dNTP levels. Suppression of infection occurred after completion of viral DNA synthesis, at the step of 2LTR circle and provirus formation. The ETO-induced block was completely rescued by depletion of SAMHD1 in MDM Concordantly, infection by HIV-2 and SIVsm encoding the SAMHD1 antagonist Vpx was insensitive to ETO treatment. The mechanism of DNA damage-induced blockade of HIV-1 infection involved activation of p53, p21, decrease in CDK1 expression, and SAMHD1 dephosphorylation. Therefore, topoisomerase inhibitors regulate SAMHD1 and HIV permissivity at a post-RT step, revealing a mechanism by which the HIV-1 reservoir may be limited by chemotherapeutic drugs.
DNA damageHIVSAMHD1integrationmacrophageCells, CulturedDNA DamageEtoposideHIV InfectionsHIV-1HumansMacrophagesNucleotidesPhosphorylationSAM Domain and HD Domain-Containing Protein 1Topoisomerase II InhibitorsVirus ReplicationTaylor, I FC00117806 Biological Sciences08 Information and Computing Sciences11 Medical and Health SciencesDevelopmental Biology